S53L (p.Ser53Leu) variant of UBQLN2 (Ubiquilin-2)

S53L (p.Ser53Leu) in UBQLN2 (Ubiquilin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.51 / 1. The record also includes population frequency data and structural context.

S53L (p.Ser53Leu) variant details